Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
WallStPal · PDF guide
ARTV Insider Trading and Fund Holdings (Artiva Biotherapeutics, Inc.) · https://wallstpal.com/stock/artv/ · saved 2026-10-28

About this page

Insider trades reported on SEC Form 4: when the people who run a company buy or sell its shares with their own money.

How to read it

Form 4
The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
Buy (P) and Sell (S)
Open-market purchases and sales. Gifts, option exercises and automatic tax withholding are left out because they say little about what the insider thinks.
Value
Shares times price, as reported on the filing.
10b5-1
A trade made under a plan set up in advance. Planned sales are common and usually say less than an unplanned purchase.
Late filing
A Form 4 filed more than two business days after the trade.
Vs. S&P 500
How the stock did after the trade minus how the overall market did in the same weeks.

A real example

In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.

Explain it like I'm 13

If the coach of a team bets his own allowance that his team will win, that tells you something. A Form 4 is the note a company boss must hand in whenever he buys or sells his own company's shares, so everyone can see it.

Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.

Summarize with AIChatGPTClaudePerplexityGoogle AIGrokCopilot
StockCIK 1817241

Artiva Biotherapeutics, Inc. (ARTV): Insider Trades and Fund Holdings

In the past 12 months, Artiva Biotherapeutics, Inc. insiders reported 16 open-market purchases worth $10.0M and 12 sales worth $2.00M; 4 of the sales were reported as made under a 10b5-1 trading plan.

16Insider buys, 12 months
$10.0MBought by insiders, 12 months
$2.00MSold by insiders, 12 months
2Tracked funds holding

Timeline: news and trades

Company filings (8-K), insider trades, notices of planned sales (Form 144), Congress trades and fund moves in the past year, newest first.

  1. Oct 27, 2026NewsCompany reported: Quarterly or annual results
  2. Oct 6, 2026Insider saleCEO Fred Aslan sold $168,880 under a 10b5-1 plan
  3. Oct 6, 2026Planned saleFRED ASLAN (director, officer) filed notice to sell about $245,735 around Oct 6, 2026
  4. Oct 5, 2026Insider saleCEO Fred Aslan sold $421,828
  5. Oct 5, 2026Insider saleChief Tech Operations Officer Christopher Horan sold $70,697
  6. Oct 5, 2026Insider saleCOO Jennifer Bush sold $57,227
  7. Oct 5, 2026Insider saleChief Medical Officer Subhashis Banerjee sold $7,514
  8. Sep 11, 2026NewsCompany reported: Executive or director change
  9. Sep 8, 2026Insider saleCEO Fred Aslan sold $255,746 under a 10b5-1 plan
  10. Sep 8, 2026Planned saleFRED ASLAN (director, officer) filed notice to sell about $262,171 around Sep 8, 2026
  11. Sep 3, 2026Insider saleCEO Fred Aslan sold $690,392
  12. Sep 3, 2026Insider saleChief Tech Operations Officer Christopher Horan sold $115,638
  13. Sep 3, 2026Insider saleCOO Jennifer Bush sold $93,606
  14. Sep 3, 2026Insider saleChief Medical Officer Subhashis Banerjee sold $12,271
  15. Aug 27, 2026Insider saleChief Medical Officer Subhashis Banerjee sold $98,736 under a 10b5-1 plan
  16. Aug 27, 2026Planned saleSUBHASHIS BANERJEE (officer) filed notice to sell about $92,018 around Aug 27, 2026
  17. Aug 18, 2026Insider saleChief Medical Officer Subhashis Banerjee sold $5,148 under a 10b5-1 plan
  18. Aug 18, 2026Planned saleSUBHASHIS BANERJEE (officer) filed notice to sell about $9,779 around Aug 18, 2026
  19. Aug 6, 2026NewsCompany reported: Quarterly or annual results
  20. Jul 31, 2026Insider buyDirector Ra Capital Management, L.P. bought $247,694
  21. Jul 29, 2026Insider buyDirector Ra Capital Management, L.P. bought $208,032
  22. Jul 24, 2026Insider buyDirector Ra Capital Management, L.P. bought $412,777
  23. Jul 23, 2026Insider buyDirector Ra Capital Management, L.P. bought $596,405
  24. Jul 22, 2026Insider buyDirector Ra Capital Management, L.P. bought $835,351
  25. Jul 21, 2026Insider buyDirector Ra Capital Management, L.P. bought $1.2 million
  26. Jul 17, 2026Insider buyDirector Ra Capital Management, L.P. bought $70,544
  27. Jul 16, 2026Insider buyDirector Ra Capital Management, L.P. bought $1.4 million
  28. Jul 13, 2026Insider buyDirector Ra Capital Management, L.P. bought $116,882
  29. Jul 10, 2026Insider buyDirector Ra Capital Management, L.P. bought $135,465
  30. Jun 30, 2026FundViking Global Investors opened a position in Q2 2026 (13F filed Aug 14, 2026)
  31. Jun 30, 2026FundRenaissance Technologies added 89% in Q2 2026 (13F filed Aug 13, 2026)
  32. Jun 26, 2026Insider buyDirector Ra Capital Management, L.P. bought $16,846
  33. Jun 25, 2026Insider buyDirector Ra Capital Management, L.P. bought $275,280
  34. Jun 16, 2026Insider buyDirector Ra Capital Management, L.P. bought $1.1 million
  35. Jun 15, 2026Insider buyDirector Ra Capital Management, L.P. bought $138,572
  36. Jun 12, 2026Insider buyDirector Ra Capital Management, L.P. bought $3.4 million

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 7, 2026.

Recent ARTV insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHoldingFiling
Oct 7Oct 6Fred AslanCEOCEO▼ SELL10b5-123,4637.20$169K−1.5%Form 4 ↗
Oct 6Oct 5Fred AslanCEOCEO▼ SELL61,6966.84$422K−3.8%Form 4 ↗
Oct 6Oct 5Christopher HoranChief Tech Operations OfficerChief Tech Operations Officer▼ SELL10,3406.84$71K−3.2%Form 4 ↗
Oct 6Oct 5Jennifer BushCOOCOO▼ SELL8,3706.84$57K−2.2%Form 4 ↗
Oct 6Oct 5Subhashis BanerjeeChief Medical OfficerChief Medical Officer▼ SELL1,0996.84$8K−0.6%Form 4 ↗
Sep 9Sep 8Fred AslanCEOCEO▼ SELL10b5-123,42910.92$256K−1.6%Form 4 ↗
Sep 4Sep 3Fred AslanCEOCEO▼ SELL61,88811.16$690K−4.0%Form 4 ↗
Sep 4Sep 3Christopher HoranChief Tech Operations OfficerChief Tech Operations Officer▼ SELL10,36611.16$116K−3.5%Form 4 ↗
Sep 4Sep 3Jennifer BushCOOCOO▼ SELL8,39111.16$94K−2.5%Form 4 ↗
Sep 4Sep 3Subhashis BanerjeeChief Medical OfficerChief Medical Officer▼ SELL1,10011.16$12K−0.8%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings
All 28 ARTV insider trades →

Insiders who traded in the past year

InsiderRoleBuysBoughtSellsSoldLatest
Fred AslanCEO0$04$1.54MOct 7, 2026
Christopher HoranChief Tech Operations Officer0$02$186KOct 6, 2026
Jennifer BushCOO0$02$151KOct 6, 2026
Subhashis BanerjeeChief Medical Officer0$04$124KOct 6, 2026
Ra Capital Management, L.P.Director16$10.0M0$0Jul 31, 2026
Strongest purchase, 12 months

37 Ra Capital Management, L.P. (Director), 2026-07-21. What the score means

Filing quality

A 1 of 28 insider trades reported after the deadline. How it is graded

Tracked funds that report ARTV

From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.

FundQuarterSharesValue% of portfolioChange
Viking Global InvestorsQ2 20262,604,166$25.3M0.07%▲ New
Renaissance TechnologiesQ2 2026151,000$1.46M0.00%▲ +88.7%
Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →